Abstract
Six infants with a history of wheezing were given temazepam syrup as sedation, to allow lung function tests to be performed. Despite doses ranging from 2.5 mg/kg–4.5 mg/kg only one infant remained a sleep for 1 h, the time taken for full lung function to be assessed. All other infants awoke within 15 min before test could be completed. Three infants developed hiccoughs and three were very irritable after awaking from sedation.
This is a preview of subscription content, log in via an institution to check access.
References
Bittercourt P, Townsend PA, Latham AN (1979) Pharmacokinetics of the hypnotic benzodiazepine, temazepam. Br J Clin Pharmacol 8:375–385
Fucella LM, Bulcioni G, Tomassia V, Ferrario L, Tungnuni G (1977) Human Pharmacokinetics and bioavailability of temazepam administered in soft gelatin capsules. Eur J Clin Pharmacol 12: 383–386
Meylens side effects of drugs (1984) Alcohols and aldehydes, 10th ed. Elsevier, Amsterdam New York Oxford, p 90
Pickup ME, Rogers MS, Lanchberg AP (1984) Temazepam elixir: comparative bioavailability with a capsule formulation. Int J Pharmaceutics 22:311–319
Smith HS (1984) Anaesthesia for radiotherapy. Can Anaesth Soc J 31:250–253
Smith GB, Hughes DG, Kumar V (1985) Temazepam in fast dispensing form as a pre-medication for children. Anaesthesia 40: 368–371
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Callaghan, C., Milner, A.D. & Swarbrick, A. Problems encountered using temazepam syrup for sedation in infants. Eur J Pediatr 147, 523–524 (1988). https://doi.org/10.1007/BF00441981
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441981